RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
68 hedge funds and large institutions have $52.9M invested in Regulus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
65% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 23
83% less call options, than puts
Call options by funds: $52K | Put options by funds: $301K
Holders
68
Holding in Top 10
–
Calls
$52K
Puts
$301K
Top Buyers
1 | +$743K | |
2 | +$542K | |
3 | +$378K | |
4 |
Morgan Stanley
New York
|
+$215K |
5 |
ARTA
A.R.T. Advisors
New York
|
+$163K |
Top Sellers
1 | -$1.47M | |
2 | -$1.39M | |
3 | -$1.26M | |
4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.08M |
5 |
A
Abingworth
London,
United Kingdom
|
-$1.08M |